Baicalin mitigates cognitive impairment and protects neurons from microglia‐mediated neuroinflammation via suppressing <scp>NLRP</scp>3 inflammasomes and <scp>TLR</scp>4/<scp>NF</scp>‐κB signaling pathway

Abstract

Overall, the results of the present study indicated that BAI is a promising neuroprotective compound for use in the prevention and treatment of microglia-mediated neuroinflammation during AD progression.